Trial Outcomes & Findings for Diabetes Self-Management Models to Reduce Health Disparities (NCT NCT01221090)

NCT ID: NCT01221090

Last Updated: 2013-10-14

Results Overview

Measures of HbA1c were collected from electronic health records dating back six months prior to orientation to the last day of study participation (45 days after the 12-month follow-up period). If a participant did not have any HbA1c value within the electronic health record for any particular follow-up visit, a lab test was scheduled to obtain a measure. Of the HbA1c collected six months prior to orientation, the value measured closest to the orientation date was considered as the baseline HbA1c value. HbA1c values that were measured on dates preceding the baseline HbA1c were not included; i.e., HbA1c values included in the analysis were those collected since the baseline HbA1c and until the last day of study participation.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

376 participants

Primary outcome timeframe

12 months

Results posted on

2013-10-14

Participant Flow

Participant milestones

Participant milestones
Measure
CDSMP
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
Combined intervention PDA/CDSMP : Combined technology and education
Control
Usual Care
Overall Study
STARTED
101
81
99
95
Overall Study
COMPLETED
86
47
57
73
Overall Study
NOT COMPLETED
15
34
42
22

Reasons for withdrawal

Reasons for withdrawal
Measure
CDSMP
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
Combined intervention PDA/CDSMP : Combined technology and education
Control
Usual Care
Overall Study
Non-Compliant or Unable to Contact
15
12
15
20
Overall Study
Withdrawal by Subject
0
22
27
2

Baseline Characteristics

Diabetes Self-Management Models to Reduce Health Disparities

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CDSMP
n=101 Participants
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
n=81 Participants
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
n=99 Participants
Combined intervention PDA/CDSMP : Combined technology and education
Control
n=95 Participants
Usual Care
Total
n=376 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Age, Categorical
Between 18 and 65 years
81 Participants
n=5 Participants
56 Participants
n=7 Participants
73 Participants
n=5 Participants
70 Participants
n=4 Participants
280 Participants
n=21 Participants
Age, Categorical
>=65 years
20 Participants
n=5 Participants
25 Participants
n=7 Participants
26 Participants
n=5 Participants
25 Participants
n=4 Participants
96 Participants
n=21 Participants
Age Continuous
56.4 years
STANDARD_DEVIATION 10.8 • n=5 Participants
57.7 years
STANDARD_DEVIATION 10.8 • n=7 Participants
57.7 years
STANDARD_DEVIATION 10.3 • n=5 Participants
58.5 years
STANDARD_DEVIATION 11.9 • n=4 Participants
57.6 years
STANDARD_DEVIATION 10.9 • n=21 Participants
Sex: Female, Male
Female
54 Participants
n=5 Participants
47 Participants
n=7 Participants
53 Participants
n=5 Participants
53 Participants
n=4 Participants
207 Participants
n=21 Participants
Sex: Female, Male
Male
47 Participants
n=5 Participants
34 Participants
n=7 Participants
46 Participants
n=5 Participants
42 Participants
n=4 Participants
169 Participants
n=21 Participants
Region of Enrollment
United States
101 participants
n=5 Participants
81 participants
n=7 Participants
99 participants
n=5 Participants
95 participants
n=4 Participants
376 participants
n=21 Participants
Minority
No
60 Participants
n=5 Participants
51 Participants
n=7 Participants
65 Participants
n=5 Participants
63 Participants
n=4 Participants
239 Participants
n=21 Participants
Minority
Yes
41 Participants
n=5 Participants
30 Participants
n=7 Participants
34 Participants
n=5 Participants
32 Participants
n=4 Participants
137 Participants
n=21 Participants
Race-Ethnicity
Non-Hispanic White
58 Participants
n=5 Participants
49 Participants
n=7 Participants
61 Participants
n=5 Participants
58 Participants
n=4 Participants
226 Participants
n=21 Participants
Race-Ethnicity
Non-Hispanic Black
21 Participants
n=5 Participants
11 Participants
n=7 Participants
12 Participants
n=5 Participants
17 Participants
n=4 Participants
61 Participants
n=21 Participants
Race-Ethnicity
Hispanic
20 Participants
n=5 Participants
19 Participants
n=7 Participants
22 Participants
n=5 Participants
15 Participants
n=4 Participants
76 Participants
n=21 Participants
Race-Ethnicity
Other
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
5 Participants
n=4 Participants
13 Participants
n=21 Participants
Education
Less than high school
6 Participants
n=5 Participants
4 Participants
n=7 Participants
3 Participants
n=5 Participants
3 Participants
n=4 Participants
16 Participants
n=21 Participants
Education
Some high school
4 Participants
n=5 Participants
3 Participants
n=7 Participants
8 Participants
n=5 Participants
1 Participants
n=4 Participants
16 Participants
n=21 Participants
Education
High school graduate
16 Participants
n=5 Participants
20 Participants
n=7 Participants
17 Participants
n=5 Participants
21 Participants
n=4 Participants
74 Participants
n=21 Participants
Education
Some college/vocational school
46 Participants
n=5 Participants
34 Participants
n=7 Participants
33 Participants
n=5 Participants
36 Participants
n=4 Participants
149 Participants
n=21 Participants
Education
College graduate
16 Participants
n=5 Participants
13 Participants
n=7 Participants
24 Participants
n=5 Participants
21 Participants
n=4 Participants
74 Participants
n=21 Participants
Education
Graduate school
13 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
13 Participants
n=4 Participants
47 Participants
n=21 Participants
Income
< $15,000
12 Participants
n=5 Participants
11 Participants
n=7 Participants
7 Participants
n=5 Participants
9 Participants
n=4 Participants
39 Participants
n=21 Participants
Income
$15,000 - $24,999
11 Participants
n=5 Participants
14 Participants
n=7 Participants
19 Participants
n=5 Participants
16 Participants
n=4 Participants
60 Participants
n=21 Participants
Income
$25,000 - $49,999
41 Participants
n=5 Participants
37 Participants
n=7 Participants
32 Participants
n=5 Participants
30 Participants
n=4 Participants
140 Participants
n=21 Participants
Income
$50,000 - $75,000
12 Participants
n=5 Participants
12 Participants
n=7 Participants
23 Participants
n=5 Participants
17 Participants
n=4 Participants
64 Participants
n=21 Participants
Income
> $75,000
12 Participants
n=5 Participants
6 Participants
n=7 Participants
14 Participants
n=5 Participants
14 Participants
n=4 Participants
46 Participants
n=21 Participants
Income
Prefer not to answer
13 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
9 Participants
n=4 Participants
27 Participants
n=21 Participants
BMI
33.5 kg/m^2
STANDARD_DEVIATION 8 • n=5 Participants
35.3 kg/m^2
STANDARD_DEVIATION 7.3 • n=7 Participants
34.6 kg/m^2
STANDARD_DEVIATION 6.3 • n=5 Participants
33.9 kg/m^2
STANDARD_DEVIATION 7.7 • n=4 Participants
34.3 kg/m^2
STANDARD_DEVIATION 7.4 • n=21 Participants
Systolic Blood Pressure
131.9 mm/Hg
STANDARD_DEVIATION 14.1 • n=5 Participants
138.5 mm/Hg
STANDARD_DEVIATION 21.2 • n=7 Participants
136.2 mm/Hg
STANDARD_DEVIATION 19.1 • n=5 Participants
132.9 mm/Hg
STANDARD_DEVIATION 21.7 • n=4 Participants
134.8 mm/Hg
STANDARD_DEVIATION 19.3 • n=21 Participants
Diastolic Blood Pressure
79.4 mm/Hg
STANDARD_DEVIATION 9.8 • n=5 Participants
73.6 mm/Hg
STANDARD_DEVIATION 11 • n=7 Participants
78.8 mm/Hg
STANDARD_DEVIATION 11.4 • n=5 Participants
75.8 mm/Hg
STANDARD_DEVIATION 13.6 • n=4 Participants
77 mm/Hg
STANDARD_DEVIATION 11.7 • n=21 Participants
HbA1c
9.4 %
STANDARD_DEVIATION 1.7 • n=5 Participants
9.3 %
STANDARD_DEVIATION 1.6 • n=7 Participants
9.2 %
STANDARD_DEVIATION 1.4 • n=5 Participants
9.2 %
STANDARD_DEVIATION 1.6 • n=4 Participants
9.3 %
STANDARD_DEVIATION 1.6 • n=21 Participants

PRIMARY outcome

Timeframe: 12 months

Population: A participant was included in the analysis if he/she had a HbA1c value collected. A longitudinal analysis was performed, with participants contributing one or more HbA1c values to the model. As such, all participants had at least one HbA1c value and were therefore included in the model.

Measures of HbA1c were collected from electronic health records dating back six months prior to orientation to the last day of study participation (45 days after the 12-month follow-up period). If a participant did not have any HbA1c value within the electronic health record for any particular follow-up visit, a lab test was scheduled to obtain a measure. Of the HbA1c collected six months prior to orientation, the value measured closest to the orientation date was considered as the baseline HbA1c value. HbA1c values that were measured on dates preceding the baseline HbA1c were not included; i.e., HbA1c values included in the analysis were those collected since the baseline HbA1c and until the last day of study participation.

Outcome measures

Outcome measures
Measure
CDSMP
n=388 HbA1c
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
n=267 HbA1c
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
n=307 HbA1c
Combined intervention PDA/CDSMP : Combined technology and education
Control
n=365 HbA1c
Usual Care
HbA1c
8.7 percentage of gycosylated HbA1c
Standard Deviation 1.9
8.7 percentage of gycosylated HbA1c
Standard Deviation 1.7
8.6 percentage of gycosylated HbA1c
Standard Deviation 1.4
8.4 percentage of gycosylated HbA1c
Standard Deviation 1.6

SECONDARY outcome

Timeframe: 12 months

Population: BMI was computed from height \& weight measurements from the 12-month follow-up (f/u) visit. Those unable to come in had height and weight abstracted from their EHRs. Measures recorded fell within the range of 10 days prior to and 45 days after participants' f/u visit dates. Those missing this information was not included in the analysis.

Body mass index

Outcome measures

Outcome measures
Measure
CDSMP
n=67 Participants
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
n=30 Participants
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
n=39 Participants
Combined intervention PDA/CDSMP : Combined technology and education
Control
n=56 Participants
Usual Care
BMI
34.9 kg/m^2
Standard Deviation 9.2
35.8 kg/m^2
Standard Deviation 7.6
32.8 kg/m^2
Standard Deviation 5.5
33.9 kg/m^2
Standard Deviation 8.4

SECONDARY outcome

Timeframe: 12 months

Population: Perceived health status was collected using a questionnaire administered during the 12-month follow-up visit. Individuals who did not complete the questionnaire during the follow-up visit or who refused to answer the question were not included in the analysis.

Outcome measures

Outcome measures
Measure
CDSMP
n=46 Participants
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
n=11 Participants
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
n=20 Participants
Combined intervention PDA/CDSMP : Combined technology and education
Control
n=30 Participants
Usual Care
Patient Self-reported Perceived Health Status
Excellent
3 participants
0 participants
1 participants
1 participants
Patient Self-reported Perceived Health Status
Very Good
13 participants
3 participants
6 participants
5 participants
Patient Self-reported Perceived Health Status
Good
19 participants
6 participants
4 participants
14 participants
Patient Self-reported Perceived Health Status
Fair
10 participants
2 participants
9 participants
8 participants
Patient Self-reported Perceived Health Status
Poor
1 participants
0 participants
0 participants
2 participants

SECONDARY outcome

Timeframe: 12 months

Population: Those who completed a questionnaire at baseline and at their 12-month visit were included. Also, they had to have answered questions regarding self-care activities on both surveys since the calculated mean was the average difference in days within the past 7 that individuals participated in self-care activities between 12-months and baseline.

Participants were asked the number of days in the past 7 which they participated in various diabetes self-care activities on diet, exercise, home blood glucose monitoring, and foot care.

Outcome measures

Outcome measures
Measure
CDSMP
n=46 Participants
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
n=11 Participants
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
n=20 Participants
Combined intervention PDA/CDSMP : Combined technology and education
Control
n=30 Participants
Usual Care
Diabetes-related Behaviors
Space carbohydrates
0.15 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.00
-0.36 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.67
0.60 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.58
0.64 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.28
Diabetes-related Behaviors
Eat packaged foods (e.g., sweets and desserts)
-0.09 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.26
0 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 0.63
0 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.68
-0.66 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.02
Diabetes-related Behaviors
Followed a healthful eating plan
0.32 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.97
-0.36 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.63
0.50 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.37
0.52 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.34
Diabetes-related Behaviors
Test blood sugar
0.26 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.01
-0.91 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.12
0.10 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.05
0.97 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.76
Diabetes-related Behaviors
Test blood sugar the recommended times
0.55 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.37
-1.22 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.28
0.11 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.40
1.21 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.28
Diabetes-related Behaviors
Exercise at least 30 minutes
0.80 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.90
0.09 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.39
-0.16 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.22
0.70 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.44
Diabetes-related Behaviors
Participate in a specific exercise session
0 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.39
-1.00 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.61
0.37 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.89
0.72 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.06
Diabetes-related Behaviors
Check feet
1.84 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.99
0.36 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.11
0.65 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.66
0.63 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.11
Diabetes-related Behaviors
Wash feet
0.52 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.55
0.09 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.70
-0.05 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.00
-0.17 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.37
Diabetes-related Behaviors
Soak feet
0.74 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.29
1.00 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.00
0.55 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.50
0.32 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.13
Diabetes-related Behaviors
Dry between toes
0.53 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.52
0.36 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.91
1.53 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.04
0.76 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.67
Diabetes-related Behaviors
Inspect inside of shoes
1.47 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.53
0.82 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.89
0.20 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.16
0.11 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 3.57
Diabetes-related Behaviors
Follow healthful eating plan
0.28 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.05
-0.36 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 1.96
0.60 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.44
0.93 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.45
Diabetes-related Behaviors
Eat 5+ servings of fruits and vegetables
0.31 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.92
0.64 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.46
0.35 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.06
1.10 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.14
Diabetes-related Behaviors
Eat high-fat foods
-0.98 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.17
1.45 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.34
0.53 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.29
-0.72 Days (e.g., Avg diff 12mo vs baseline)
Standard Deviation 2.20

SECONDARY outcome

Timeframe: 12 months

Population: Participants were included if they completed the 12-mo follow-up questionnaire. They also had to have answered questions pertaining to quality of life. Missing responses were not included.

Participants where asked the number of days in the past 30 days in which their physical (phys) and/or mental was not good, and whether their usual activity was affected by their physical/mental health.

Outcome measures

Outcome measures
Measure
CDSMP
n=46 Participants
6-week educational classes CDSMP : 6-week classes
Personal Digital Assistant (PDA)
n=11 Participants
Personal digital assistance (technological) PDA : Technological assistance
PDA/CDSMP
n=20 Participants
Combined intervention PDA/CDSMP : Combined technology and education
Control
n=30 Participants
Usual Care
Quality of Life (QOL)
Mental health was not good in the past 30 days
6.8 Number of days
Standard Deviation 9.6
7.2 Number of days
Standard Deviation 12.6
7.3 Number of days
Standard Deviation 11.0
6.6 Number of days
Standard Deviation 10.2
Quality of Life (QOL)
Poor phys/mental health prevented usual activities
3.8 Number of days
Standard Deviation 7.2
7.3 Number of days
Standard Deviation 12.6
7.8 Number of days
Standard Deviation 9.1
5.4 Number of days
Standard Deviation 9.3
Quality of Life (QOL)
Physical health was not good in the past 30 days
5.9 Number of days
Standard Deviation 8.7
9.0 Number of days
Standard Deviation 11.7
8.5 Number of days
Standard Deviation 10.2
7.3 Number of days
Standard Deviation 8.8

Adverse Events

CDSMP

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Personal Digital Assistant (PDA)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

PDA/CDSMP

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Samuel N. Forjuoh

Scott & White Hospital

Phone: (254) 771-7695

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place